Welcome to our list of WIT mentors.  The mentors are shown by TTS region (i.e., Asia, Europe, Latin America, Middle East and Africa, North America and finally Oceania).


We suggest that you read the biographies of any of the mentors you are interested in (click on the bio tab next to their picture and you will be taken to their information) and when you are ready to select your mentors, return to your mentee application form (go to the Mentoring Scheme menu and choose 'become a mentee') and choose your mentors from the drop down boxes in the form.


WIT Membership is required participate in the Mentoring Scheme. Please take a moment to signup prior to accessing the mentee application form.

Anat R Tambur, DMD, PhD, D. ABHI – has been serving as the Director of the Transplant Immunology Laboratory at the Comprehensive Transplant Center, Northwestern University, Chicago, Illinois, since July 2004 and is a Research Professor in the Department of Surgery at that institution. Prior to that, Anat was the HLA Laboratory Director at Rush Medical Center, senior investigator with the Neurosurgery Stem Cell Transplant group at UIC, and an investigator with the Heart Transplant Program at Rush Medical Center, Chicago, IL. After serving in the Israeli Defense Forces, Anat received her DMD degree from the Hebrew University School of Dental Medicine, Jerusalem Israel in 1987 and her PhD degree in Immunogenetics from the Hebrew University School of Medicine, Jerusalem Israel in 1993. She received her board certification as an HLA laboratory director and diplomate of the American Board of Histocompatibility and Immunogenetics in 1998.

Anat’s current research efforts are focused on understanding the role of donor-specific HLA antibodies in the context of solid organ transplantation with specific emphasis on the significance of antibody affinity and strength. A substantial part of that work is dedicated to the understanding of the newly emerging concept of HLA epitopes. Anat is also working in the field of human regulatory T cells, both CD4 and CD8, and their role in induction of donor-specific unresponsiveness. Anat had served in leadership positions with the American Society for Histocompatibility and Immunogenetics (ASHI) as committee member, committee chair and a board member for ASHI; president of the American Board of Histocompatibility and Immunogenetics (ABHI) and is a peer reviewer for publications such as American Journal of Transplantation, Transplantation, Human Immunology and others.